Cost-effectiveness analysis of hormone replacement therapy and lifestyle intervention for hip fracture.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Australian Journal of Public Health

• Publication date

  2010-02-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1753-6405.1994.TB00217.XPMID 7948331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

  2004cited by this paper
• Cost-effectiveness league tables: more harm than good?

  1993cited by this paper
• A cost‐effectiveness analysis of hormone replacement therapy in the menopause∗

  1992cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper
• HRT: an analysis of benefits, risks and costs.

  1992cited by this paper
• Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy.

  1991cited by this paper
• Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆

  1991cited by this paper
• A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

  1991cited by this paper
• Prevalence and Characteristics of Women Who Have Had a Hysterectomy in a Community Survey

  1991cited by this paper
• Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group.

  1991cited by this paper
• Strategies for prevention of osteoporosis and hip fracture.

  1991cited by this paper
• A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.

  1991cited by this paper
• Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy.

  1990cited by this paper
• Cardiovascular implications of estrogen replacement therapy.

  1990cited by this paper
• A quantitative analysis of placental vasculature in the third‐trimester fetus with autosomal trisomy

  1990cited by this paper
• Appendicular Bone Density and Age Predict Hip Fracture in Women

  1990cited by this paper
• Cardiovascular implications of estrogen replacement therapy

  1990cited by this paper
• Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry?

  1990cited by this paper
• Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group.

  1990cited by this paper
• Accumulation of Penicillin in Vaginal Fluid

  1990cited by this paper
• The Role and Use of Progestogens

  1990cited by this paper
• The risk of breast cancer after estrogen and estrogen-progestin replacement.

  1989cited by this paper
• Re-evaluating the role of progestogen therapy after the menopause.

  1988cited by this paper
• A cost-effectiveness analysis of exercise as a health promotion activity.

  1988cited by this paper
• Postmenopausal oestrogen treatment and stroke: a prospective study.

  1988cited by this paper
• The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.

  1988cited by this paper
• Lifetime fracture risk: an approach to hip fracture risk assessment based on bone mineral density and age.

  1988cited by this paper
• Osteoporosis, falls, and age in fracture of the proximal femur.

  1987cited by this paper
• Compliance with hormone therapy.

  1987cited by this paper
• Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry.

  1987cited by this paper
• Long-term effects of postmenopausal hormone therapy.

  1987cited by this paper
• Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

  1987cited by this paper
• Estrogen therapy arrests bone loss in elderly women.

  1987cited by this paper
• Femoral neck fractures: admissions, bed use, outcome and projections

  1986cited by this paper
• Menopausal oestrogens and breast cancer risk: an expanded case-control study.

  1986cited by this paper
• Epidemiology of osteoporosis and osteoporotic fractures.

  1985cited by this paper
• Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.

  1985cited by this paper
• Long-term estrogen replacement therapy prevents bone loss and fractures.

  1985cited by this paper
• The determination of the incidence of acute myocardial infarction from hospital morbidity records.

  1984cited by this paper
• "Though Much is Taken" -- Reflections on Aging, Health, and Medical Care

  1984cited by this paper
• Cost-effectiveness of hormone replacement therapy in the menopause.

  1983cited by this paper
• Menopausal estrogen therapy and hip fractures.

  1981cited by this paper
• The risk of hip fracture in postmenopausal females with or without estrogen drug exposure.

  1981cited by this paper
• Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.

  1980cited by this paper
• Oestrogen use and survival in endometrial cancer.

  1980cited by this paper
• A case-control study of menopausal estrogen therapy and breast cancer.

  1980cited by this paper
• ŒSTROGEN USE AND SURVIVAL IN ENDOMETRIAL CANCER

  1980cited by this paper
• Effect on bone of withdrawal of oestrogen therapy.

  1979cited by this paper
• POST-MENOPAUSAL ŒSTROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS: A Case-control Study

  1979cited by this paper
• Bf IN INSULIN-DEPENDENT DIABETES MELLITUS

  1979cited by this paper
• Effect on bone of withdrawal of oestrogen therapy.

  1979cited by this paper
• Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study.

  1979cited by this paper
• Incidence of Hysterectomy in Australia

  1978cited by this paper
• BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENT

  1978cited by this paper
• Estrogen use and stroke risk in postmenopausal women.

  1976cited by this paper

• Assessing Generalisability in Model-Based Economic Evaluation Studies

  2012cites this paper
• Cost Effectiveness of Nasal Calcitonin in Postmenopausal Women

  2012cites this paper
• The cost-effectiveness of total joint arthroplasty: a systematic review of published literature.

  2012cites this paper
• Hip Fracture Prevention

  2012cites this paper
• Principles of health economics and application to rheumatic disorders

  2011cites this paper
• Cost-Effectiveness of Interventions for Musculoskeletal Conditions

  2006cites this paper
• BURDEN OF MUSCULOSKELETAL DISEASE

  2006cites this paper
• Bone health in urban midlife Malaysian women: risk factors and prevention

  2005cites this paper
• PROFICIENCY CONTINUING EDUCATION : PHARMACY PRACTICE IN THE LONG-TERM CARE ENVIRONMENT LEARNING

  2005cites this paper
• Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature

  2005cites this paper
• An anthropological perspective on optimizing calcium consumption for the prevention of osteoporosis

  2005cites this paper
• Cost-utility analyses in orthopaedic surgery.

  2005cites this paper
• Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: Results based on the Women's Health Initiative randomized controlled trial

  2004cites this paper
• Generalisability in economic evaluation studies in healthcare: a review and case studies.

  2004cites this paper
• Cost-effectiveness of fracture prevention treatments in the elderly

  2004cites this paper
• Planning Clinical Trials

  2003cites this paper
• Bisphosphonates for the Prevention and Treatment of Osteoporosis

  2003cites this paper
• [Postmenopausal osteoporosis. Clinical practice guide].

  2003cites this paper
• Models for Assessing the Cost-Effectiveness of the Treatment and Prevention of Osteoporosis

  2002cites this paper
• Economics notes: Converting international cost effectiveness data to UK prices.

  2002cites this paper
• Scottish Intercollegiate Guidelines Network Prevention and Management of Hip Fracture in Older People

  2002cites this paper
• THE HEALTH ECONOMICS OF CALCIUM AND VITAMIN D3 FOR THE PREVENTION OF OSTEOPOROTIC HIP FRACTURES IN SWEDEN

  2002cites this paper
• [Pharmaco-economic evaluation of drug therapy osteoporosis. A literature review].

  2002cites this paper
• Converting international cost effectiveness data to UK prices

  2002cites this paper
• Do HEDIS measures reflect cost-effective practices?

  2002cites this paper
• [Pharmacoeconomic aspects of treating osteoporosis].

  2002cites this paper
• The impact of risk on preference values: implications for evaluations of postmenopausal osteoporosis therapy.

  2001cites this paper
• Hip fracture prevention: cost-effective strategies.

  2001cites this paper
• How to diagnose the presence of osteoporosis and assess the risk of fracture.

  2001cites this paper
• A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden

  2001cites this paper
• Cost-utility analyses of clinical preventive services1

  2000cites this paper
• CHAPTER 46 – Decision Analysis Applied to Postmenopausal Hormone Replacement Therapy

  2000cites this paper
• Cost-utility analyses of clinical preventive services: published ratios, 1976-1997.

  2000cites this paper
• Preference-based measures in economic evaluation in health care.

  2000cites this paper
• Cost‐effectiveness research in osteoporosis

  2000influential citation
• Cost-effectiveness of lifestyle and structured exercise interventions in sedentary adults: results of project ACTIVE.

  2000cites this paper
• Has the Impact of Hormone Replacement Therapy on Health-Related Quality of Life Been Undervalued?

  2000cites this paper
• MODELING AGE DIFFERENCES IN COST-EFFECTIVENESS ANALYSIS

  2000cites this paper
• A review of economic evaluation in osteoporosis.

  1999cites this paper
• Proven Strategies to Improve Older People's Health

  1999cites this paper
• Current controversies in cost effectiveness analysis of osteoporosis therapies.

  1999cites this paper
• A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis

  1999cites this paper
• Lifestyle physical activity interventions. History, short- and long-term effects, and recommendations.

  1998cites this paper
• Is There an Association between Hormone Replacement Therapy and Breast Cancer?

  1998cites this paper
• Relationship of compliance with hormone replacement therapy to short-term healthcare utilization in a managed care population.

  1998cites this paper
• A summary of economic evaluations published in the field of rheumatology and related disciplines.

  1997cites this paper
• Osteoporosis--emerging consensus.

  1997cites this paper
• Estrogen therapy and osteoporosis: principles & practice.

  1997cites this paper
• Calcium and osteoporosis.

  1997cites this paper
• The Osteoporosis Revolution

  1997cites this paper
• Modelling in economic evaluation: an unavoidable fact of life.

  1997cites this paper
• The economics of osteoporosis prevention.

  1997cites this paper
• The economics of osteoporosis and its prevention. A review.

  1997cites this paper
• The management of osteoporosis.

  1997cites this paper
• First- and second-year effects in trials of calcium supplementation on the loss of bone density in postmenopausal women.

  1997cites this paper
• The Economics of Osteoporosis and Its Prevention

  1997cites this paper
• Estimating the cost per avoided hip fracture by osteoporosis treatment in Italy.

  1997cites this paper
• Modelling in Medical Technology Assessment

  1996cites this paper
• Bone Mineral Density Measurements: Are they Worth While?

  1996cites this paper
• Hormone replacement therapy and breast cancer: what are the facts?

  1996cites this paper
• Screening and treatment in the elderly to reduce osteoporotic fracture risk.

  1996cites this paper
• Prescription for poisoning

  1995cites this paper
• Why elderly women should be screened and treated to prevent osteoporosis.

  1995cites this paper
• When should postmenopausal women start taking oestrogen replacement therapy?

  1995cites this paper